Stratec

Delve deeper into the various fields of application where STRATEC has established a wide-ranging expertise.

STRATEC’s portfolio includes consulting, development, and production of smart consumables for IVD and life sciences.

STRATEC collaborates with clients to develop custom automation solutions for businesses.

STRATEC’s portfolio includes consulting, development, and production of instruments for diagnostic and life science solutions.

The page lists upcoming events where STRATEC will participate.

The page provides access to presentations from selected conferences and upcoming events.

The page offers a subscription to STRATEC’s Investor Relations Newsletter.

The page offers access to press releases, pictures, and brochures in STRATEC’s Mediacenter.

The page details the STRATEC site in Anif, Austria.

The page describes the STRATEC group and its company culture.

The page introduces the STRATEC team located in Birkenfeld, Germany.

The page provides information about STRATEC’s subsidiary Diatron in Budapest, Hungary.

The page outlines STRATEC’s Corporate Compliance policy and reporting procedure.

STRATEC integrates corporate social responsibility into its operations, addressing people, community, and the environment.

The page provides contact details for STRATEC’s Investor Relations Team.

STRATEC designs and manufactures fully automated analyzer systems, software and smart consumables for OEM partners in the fields of clinical diagnostics and life sciences.

The page explains STRATEC’s governance of company structure, operations, and decision-making processes.

Stratec SE sells its loss-making business unit to streamline operations. The company recognizes significant impairments and revises its 2024 financial guidance downward. This move follows ongoing challenges in the segment’s profitability and market positioning.

Oct 2026biotech-365.comNews article

Stratec SE reports a **strong recovery in Q2 2026**, driven by improved demand and operational efficiency. The company highlights a **robust cash position**, reinforcing financial stability amid market volatility. Executives emphasize strategic initiatives to sustain growth in core segments, including medical technology and industrial solutions.

Aug 2026Yahoo FinanceNews article

STRATEC SE reports its financial performance for the first half of 2026. The company provides updates on its operational and financial status without detailing specific figures in this brief release.

Aug 2026FinanzwireNews article

Stratec SE discusses its first-quarter financial performance and operational updates during an earnings call. The company outlines key metrics and strategic priorities for investors. Analysts and market observers focus on its growth trajectory in medical technology.

May 2026Yahoo FinanceNews article